Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS‐165 DARULIGHT study

Article date: January 2019

By: Minh P. Lê, Marie‐Laure Chaix, François Raffi, Sylvie Chevret, Sébastien Gallien, Christine Katlama, Pierre Delobel, Yazdan Yazdanpanah, Juliette Saillard, Jean‐Michel Molina, Gilles Peytavin, the ANRS‐165 DARULIGHT study group, the ANRS‐165 DARULIGHT study group in Volume 85, Issue 1, pages 277-280